<Anchor>



US President Biden signed an executive order emphasizing US production in the bio industry following semiconductors, batteries and electric vehicles.

If discriminatory benefits are given only to production in the United States like electric vehicles, there are concerns about damage to the domestic bio industry.



This is Washington correspondent Yunsu Kim.



<Reporter>



The essence of the executive order signed by President Biden is that what the United States invents in the field of biotechnology is made in the United States.



The White House explained that the U.S. has been too dependent on foreign countries for raw materials and production in the bio sector.



After allowing the relocation of production facilities overseas, it is now a situation where we have to worry about weakening the competitiveness of the United States.



Following semiconductors, batteries, and electric vehicles, the plan is to bring overseas bio plants to the United States, and President Biden also mentioned attracting investment from Korea as an achievement.



[Biden/President of the United States: Korean companies have invested hundreds of billions of dollars in semiconductor factories in the United States.

When I asked them why they came to the United States, they said that it was because the United States was the safest country.] As



if conscious of the midterm elections, he also emphasized that investment in the bio industry will lead to benefits for Americans, such as conquering cancer.



[Biden/President of the United States: The goal is to reduce cancer mortality in the United States by at least half within the next 25 years.

It will make cancer no longer a death sentence, but a chronic disease.]



The White House will hold a meeting tomorrow (14th) to discuss new investment plans related to the executive order.



For Korean biotech companies that are consigning U.S. drugs such as coronavirus vaccines, damage is inevitable if the U.S. government encourages domestic production instead of consignment production.



As the strengthening of the U.S. preference for electric vehicles has led to discrimination against Korean electric vehicles, attention is focused on how much this executive order will affect the domestic bio industry.



(Video coverage: Oh Jeong-sik)